Navigation Links
Oncology group chooses Sanford Health for first clinical trial
Date:4/20/2017

A new clinical trial at Sanford Health examines whether medications that are FDA-approved for one cancer can effectively treat another.

Sanford Health locations in Sioux Falls, Fargo and Bismarck are participating in this national effort. The Targeted Agent and Profiling Utilization Registry Study, or TAPUR, is sponsored by the American Society of Clinical Oncology, the world’s leading organization representing oncologists.

Precision medicine, which targets treatments based on genetics and changes unique to a specific person’s cancer, allows oncologists to provide individualized treatments that attack cancer at a molecular level.

“Precision cancer therapy shows great promise, but despite our advances in genetic testing, treatment options have been limited,” said Steven Powell, M.D., the principal investigator for Sanford Health sites. “ASCO’s TAPUR study will increase the treatment options for our patients.”

Patients who have had genomic testing and are identified to have a targetable alteration qualify for the study and will gain access to treatments matched to their needs. Right now, the study is for adults with advanced cancers that have progressed on standard therapy or for whom no standard therapy exists.

Three medical oncologists from Sanford Health are principal investigators in the trial: Steven Powell, M.D., Sioux Falls; Anu Gaba, M.D., Fargo; and John Reynolds, M.D., Bismarck.

Seven pharmaceutical companies are participating and have volunteered to give medications to this effort. As more companies sign on, more drugs that target additional cancers may be added to the trial. AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly and Co., Genetech, Merck and Pfizer are participating.

The study is open to cancer patients ages 18 and older who are no longer benefitting from standard anti-cancer treatment. To enroll, call 1-87-SURVIVAL.

About Sanford Health
Sanford Health is an integrated health system headquartered in the Dakotas. It is one of the largest health systems in the nation with 45 hospitals and nearly 300 clinics in nine states and four countries. Sanford Health’s 28,000 employees, including more than 1,300 physicians, make it the largest employer in the Dakotas. Nearly $1 billion in gifts from philanthropist Denny Sanford have allowed for several initiatives, including global children's clinics, genomic medicine and specialized centers researching cures for type 1 diabetes, breast cancer and other diseases. For more information, visit sanfordhealth.org.

Read the full story at http://www.prweb.com/releases/2017/04/prweb14258133.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Orphan Drugs in Oncology Drug Pipeline Update 2013
2. Neuro-Oncology Pioneer Who Defined Standard of Care for Brain and Spinal Tumors Joins Capital Institute for Neurosciences
3. Oncology Leads Biosimilars Market Growth to 2018 Forecasts in New Research Report at RnRMarketResearch.com
4. Growth of Mice Model Industry (Oncology, Immunology, CNS) with 2018 Forecasts in a New Research Report at RnRMarketResearch.com
5. Personalized Medicine in Oncology Partnering Terms and Agreements, a New Research Report at ReportsnReports.com
6. Dr. Neal Meropol honored as American Society of Clinical Oncology Fellow
7. Mount Sinai researchers to present studies at American Society of Clinical Oncology Meeting
8. American Society of Clinical Oncology recognizes MD Anderson leaders for their contributions to cancer research
9. ASTRO and AAPM announce launch of RO-ILS: Radiation Oncology Incident Learning System
10. Special edition of the Red Journal highlights the need for radiation oncology services in LMICs
11. The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Brady ... announced that its B-595 and B-7569 vinyl label materials received ... and warning labels are tested to remain intact and legible, for use on chemical ...
(Date:4/21/2017)... Colo. (PRWEB) , ... April 21, 2017 , ... The ... the Flex House, the next project in the company’s esteemed VISION House demonstration project ... homeowners use exactly the amount of resources they need to live affordably and abundantly ...
(Date:4/21/2017)... ... ... The Hong Kong Polytechnic University (PolyU) launched today the University Research Facility in ... Kong to support teaching, learning and research. It is also the largest research centre ... Kong. , With an area of 620 square metres and more than 50 ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Alive ... people who wish to overcome their mental health struggles. The Alive team uses ... LeBouthillier says: “Our approach in dealing with a mental health struggle is based on ...
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens ... of International Trade, the UK’s most prestigious award for business success. The ... of total revenues and has grown by a total of 400% over the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it ... 2017 at the Sheraton Hotel in Toronto, Ontario ... the Company is scheduled to present on Tuesday, May 2 at ... Chairman of the Board, Tony Holler will also attend ... For more details ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
(Date:4/19/2017)... April 19, 2017  New research provides evidence that an ... according to a study released today that will be presented ... in Boston , April 22 to ... treatment of Parkinson,s disease, the oral drug levodopa has long ... longevity. But as the disease progresses, the effects of the ...
Breaking Medicine Technology: